As a leading global provider of biospecimens and value-added services, BioIVT understands your needs when it comes to rare cancer, precancerous, or benign-related specimens. With the ability to ethically collect diseased biospecimens as well as donor-matched and control true normal biospecimens, as well as the ability to customize collections to fit-for-purpose use, BioIVT is your partner in ELEVATING SCIENCE.
BioIVT’s clinical specimens now include the ASTERAND Human Tissue Specimens and include rare cancer, precancerous, or benign-related collected as surgical discards, while biofluids include blood-derived as well as other biofluids. Matched biofluids are available for select cases. With board-certified pathological confirmation of disease and correlation with clinical staging, matched with the ability to designate specific inclusion/exclusion criteria related to stage, treatment, race/ethnicity, age, relevant mutation status, comorbidities and outcome, you know the specimen you are working with is exactly the specimen your research requires.